Section Arrow
VYNE.NASDAQ
- VYNE Therapeutics
(Financial Status)
Quotes are at least 15-min delayed:2026/05/27 08:03 EDT
Pre Market
Last
 0.661
-0.0185 (-2.72%)
Bid
0.6601
Ask
0.6846
High 0.661 
Low 0.6601 
Volume 696 
Regular Hours (Closed)
Last
 0.6795
+0.0081 (+1.21%)
Day High 
0.684 
Prev. Close
0.6714 
1-M High
0.69 
Volume 
122.48K 
Bid
0.6601
Ask
0.6846
Day Low
0.6601 
Open
0.6798 
1-M Low
0.62 
Market Cap 
22.39M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 0.67 
20-SMA 0.66 
50-SMA 0.63 
52-W High 1.96 
52-W Low 0.2805 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.50/-0.64
Enterprise Value
22.39M
Balance Sheet
Book Value Per Share
0.74
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
570.00K
Operating Revenue Per Share
0.01
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
OTLKOutlook Therapeutics0.4002+0.0903+29.14%-- 
Pre Market 0.3991 -0.0011 -0.27%
SNGXSoligenix Inc.0.513+0.1229+31.50%-- 
Pre Market 0.9999 +0.4869 +94.91%
PHGEBiomX Inc.1.62+0.8035+98.41%-- 
Pre Market 1.325 -0.295 -18.21%
RXRXRecursion Pharmaceuticals2.97-0.04-1.33%-- 
Pre Market 2.965 -0.005 -0.17%
ARTLArtelo Biosciences Inc1.71+0.52+43.70%-- 
Pre Market 1.26 -0.45 -26.32%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary and differentiated therapies for the treatment of immuno-inflammatory conditions. The company is also in the pre-clinical stages of research, develop and commercialize products containing small molecule bromodomain and extra-terminal domain (BET) inhibitors for the treatment of any disease, disorder or condition in human. Its products include AMZEEQ, ZILXI, and FCD105.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.